特应性皮炎与14种特定部位癌症风险的孟德尔随机化研究
该研究采用两样本孟德尔随机化方法,基于特应性皮炎(AD)大规模GWAS数据(10,788例病例和30,047例非病例)筛选工具变量,评估AD与14种特定部位癌症及总体癌症风险的因果关联。结果显示,AD与总体癌症风险无显著因果关联(UK Biobank:OR 1.00,95%CI 0.94-1.06,FDR 0.98;FinnGen:OR 0.96,95%CI 0.92-1.02,FDR 0.68),且与任何特定部位癌症均无强证据关联。
要点
- 孟德尔随机化分析未发现AD对总体癌症风险有因果效应。
- AD与14种特定部位癌症风险均无强证据关联。
- 结果经Benjamini-Hochberg校正及多项敏感性分析验证。
核心结论
- 孟德尔随机化研究不支持AD对癌症风险存在因果效应。
研究设计与样本
- 两样本孟德尔随机化研究,从AD的GWAS(10,788例病例和30,047例非病例)中选取与AD高度相关(p < 5 × 10-8)的遗传变异作为工具变量。
- 癌症数据来自大型癌症联盟、UK Biobank(n = 442,239)和FinnGen研究(n = 218,792),评估14种特定部位癌症及总体癌症。
主要发现
- AD对总体癌症风险无强因果证据,效应估计值接近零。
- UK Biobank中AD与总体癌症风险无关联(OR 1.00,95%CI 0.94-1.06,FDR 0.98)。
- FinnGen中AD与总体癌症风险无关联(OR 0.96,95%CI 0.92-1.02,FDR 0.68)。
- 未发现遗传预测的AD与任何特定部位癌症风险之间存在强证据关联。
临床怎么用
- 该发现对AD和癌症的预防与管理有重要意义,降低了AD对癌症结局潜在不良影响的担忧。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis (AD) accounts for a large proportion of the burden of skin disease, with a prevalence of around 10% among adults worldwide. In addition, systematic reviews and meta-analyses have found that AD is associated with cancer risk at several sites; if found to be causal this could highlight potential treatment targets to reduce cancer risk. OBJECTIVES: To assess the potential causative link between AD and 14 site-specific cancers in a two-sample randomization study. METHODS: From the largest genome-wide association study (GWAS) of AD (10,788 cases and 30,047 non-cases), genetic variants highly associated (p < 5 × 10-8 ) with AD in the European population were selected as instrumental variables (IVs). Data from large cancer consortia, as well as the UK Biobank study (n = 442,239) and the FinnGen study (n = 218,792), were employed to assess genetic associations with 14 site-specific cancers and overall cancer. A set of complementary approaches and sensitivity analyses were carried out to examine the robustness of our results. In addition, associations for the same cancer site from different data sources were combined using meta-analyses. RESULTS: We discovered no strong causal evidence of AD on the risk of overall cancer, with effect estimates close to zero. After the Benjamini-Hochberg correction, the inverse-variance weighted method indicated no association between AD and overall cancer risk in both the UK Biobank (OR, 1.00; 95% CI, 0.94-1.06; FDR, 0.98) and FinnGen studies (OR, 0.96; 95% CI, 0.92-1.02; FDR, 0.68). No strong evidence of an association was found between genetically predicted AD and the risk of any site-specific cancers. CONCLUSIONS: Our MR investigation does not support a causal effect of AD on cancer risk. This finding has important implications for the prevention and management of both AD and cancer, as it reduces the concern of potential adverse effects of AD on cancer outcomes.
引用
- Liu Q, Chen L, Wang Y, et al. Atopic dermatitis and risk of 14 site-specific cancers: A Mendelian randomization study. J Eur Acad Dermatol Venereol. 2023. PMID: 37478287. doi:10.1111/jdv.19380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。